Accustem Sciences Inc.
ACUT · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Cerrone Gabriele M: Form 4
Insider disclosure · Filed · Report period 13 Jun 2025
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ACUT · 00444A101 - ACUT
Company details and SEC sources
CIK 0001850767 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ACUT on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 5 Penn Plaza, 19 Th Floor, #1954, New York, NY, 10001
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- AccuStem Sciences Ltd (to 01 Jul 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields